Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
A mouse model of human oral-esophageal cancer
Oliver G. Opitz, … , Hiroshi Nakagawa, Anil K. Rustgi
Oliver G. Opitz, … , Hiroshi Nakagawa, Anil K. Rustgi
Published September 15, 2002
Citation Information: J Clin Invest. 2002;110(6):761-769. https://doi.org/10.1172/JCI15324.
View: Text | PDF
Article Genetics

A mouse model of human oral-esophageal cancer

  • Text
  • PDF
Abstract

Research Article

Authors

Oliver G. Opitz, Hideki Harada, Yasir Suliman, Ben Rhoades, Norman E. Sharpless, Ralph Kent, Levy Kopelovich, Hiroshi Nakagawa, Anil K. Rustgi

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
(a) Northern blot analysis with a random-primed, 32P-labeled human cycli...
(a) Northern blot analysis with a random-primed, 32P-labeled human cyclin D1 cDNA probe in three different founder lines with low, moderate, and high cyclin D1 expression in tongue (T) and esophageal (E) tissues. (b) Tongue and esophageal epithelial protein extracts from mice expressing moderate levels of cyclin D1 were immunoprecipitated with Cdk4 or Cdk6 antibody. After a kinase reaction with [γ-32P]ATP and GST-retinoblastoma carboxyl-terminus substrate (GST-Rb c-term) or histone H1 substrate, products were electrophoresed on a 12.5% SDS-polyacrylamide gel.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts